02/17/2026
🔬 A significant advancement in sulforaphane science.✨
A newly published randomized, double-blind human clinical trial demonstrates a measurable improvement in sulforaphane conversion using TrueBroc® glucoraphanin — developed by Brassica Protection Products.
When paired with active mustard seed–derived myrosinase, bioavailability increased from 19% to 40% — effectively doubling conversion efficiency in humans. 📈
Early-phase absorption (0–8 hours) was more than threefold higher when myrosinase was included, supporting small-intestinal formation rather than reliance solely on colonic microbiota.
For decades, Paul Talalay, MD and Jed W. Fahey, ScD laid the scientific foundation for sulforaphane and Nrf2 biology. Brassica Protection Products was founded to translate that legacy into standardized, clinically reliable ingredients.
This study reinforces that mission — advancing precision in conversion and strengthening the scientific integrity behind TrueBroc®. 🛡️
Read the full publication in Scientific Reports (Nature Portfolio):
https://www.nature.com/articles/s41598-026-39389-4
🥦 TrueBroc® — A legacy of broccoli science advancing cellular defense.